AR241439A1 - Preparacion de n-tiazolil-metiltio-alquil-n'-(ciano, carbamoil, nitro p-alquilfenilsulfonil o alquilsulfonil) guanidinas o n'-ciano carbamido tioatos. - Google Patents

Preparacion de n-tiazolil-metiltio-alquil-n'-(ciano, carbamoil, nitro p-alquilfenilsulfonil o alquilsulfonil) guanidinas o n'-ciano carbamido tioatos.

Info

Publication number
AR241439A1
AR241439A1 AR82291229A AR29122982A AR241439A1 AR 241439 A1 AR241439 A1 AR 241439A1 AR 82291229 A AR82291229 A AR 82291229A AR 29122982 A AR29122982 A AR 29122982A AR 241439 A1 AR241439 A1 AR 241439A1
Authority
AR
Argentina
Prior art keywords
alkyl
formula
compounds
relating
thiazole derivatives
Prior art date
Application number
AR82291229A
Other languages
English (en)
Spanish (es)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22712591&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR241439(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of AR241439A1 publication Critical patent/AR241439A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AR82291229A 1980-10-02 1982-11-09 Preparacion de n-tiazolil-metiltio-alquil-n'-(ciano, carbamoil, nitro p-alquilfenilsulfonil o alquilsulfonil) guanidinas o n'-ciano carbamido tioatos. AR241439A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/193,192 US4375547A (en) 1980-10-02 1980-10-02 N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine

Publications (1)

Publication Number Publication Date
AR241439A1 true AR241439A1 (es) 1992-07-31

Family

ID=22712591

Family Applications (1)

Application Number Title Priority Date Filing Date
AR82291229A AR241439A1 (es) 1980-10-02 1982-11-09 Preparacion de n-tiazolil-metiltio-alquil-n'-(ciano, carbamoil, nitro p-alquilfenilsulfonil o alquilsulfonil) guanidinas o n'-ciano carbamido tioatos.

Country Status (36)

Country Link
US (1) US4375547A (OSRAM)
EP (1) EP0049618B1 (OSRAM)
JP (1) JPS5791980A (OSRAM)
KR (1) KR850001795B1 (OSRAM)
AR (1) AR241439A1 (OSRAM)
AU (1) AU542553B2 (OSRAM)
BG (1) BG60249B1 (OSRAM)
CA (1) CA1166248A (OSRAM)
CS (1) CS227015B2 (OSRAM)
CY (1) CY1351A (OSRAM)
DD (1) DD200371A5 (OSRAM)
DE (1) DE3171819D1 (OSRAM)
DK (2) DK164056C (OSRAM)
EG (1) EG15678A (OSRAM)
ES (2) ES8301950A1 (OSRAM)
FI (2) FI76570C (OSRAM)
GB (1) GB2084581B (OSRAM)
GR (1) GR75023B (OSRAM)
HK (1) HK15987A (OSRAM)
HU (1) HU188697B (OSRAM)
IE (1) IE51603B1 (OSRAM)
IL (1) IL63980A (OSRAM)
LU (1) LU88293I2 (OSRAM)
MX (1) MX5723A (OSRAM)
MY (1) MY8700247A (OSRAM)
NL (1) NL930107I2 (OSRAM)
NO (1) NO155885C (OSRAM)
NZ (1) NZ198523A (OSRAM)
PH (1) PH18135A (OSRAM)
PL (2) PL130626B1 (OSRAM)
PT (1) PT73757B (OSRAM)
RO (2) RO82215A (OSRAM)
SU (1) SU1184443A3 (OSRAM)
UA (1) UA6081A1 (OSRAM)
YU (1) YU42728B (OSRAM)
ZA (1) ZA816817B (OSRAM)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904792A (en) * 1980-10-02 1990-02-27 Eli Lilly And Company N-thiazolymethylthioalkyl-N'-alkylamidines and related compounds
CA1206151A (en) * 1981-12-28 1986-06-17 Richard P. Pioch Pyrimidone anti-ulcer agents
US4474794A (en) * 1982-03-19 1984-10-02 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N1 -alkenyl (or alkynyl)guanidines and related compounds
FR2531703A1 (fr) * 1982-08-13 1984-02-17 Sanofi Sa 2-aza-5-thiahexan-1-ones 1,6-disubstituees, leurs sels, procede pour leur preparation et compositions pharmaceutiques les renfermant
ATE84530T1 (de) * 1983-02-07 1993-01-15 Lilly Co Eli Synthese von nizatidin.
US4587344A (en) * 1983-02-07 1986-05-06 Eli Lilly And Company Isothiourea synthesis process
US4468517A (en) * 1983-05-12 1984-08-28 Eli Lilly And Company Synthesis of thiazoles
DE3417127A1 (de) * 1984-05-09 1985-11-14 Papst-Motoren GmbH & Co KG, 7742 St Georgen Kleinstventilator
DE3531504A1 (de) * 1985-09-04 1987-03-12 Basf Ag 3-aminomethylpyrrol-1-yl-alkylamine und diese verbindungen enthaltende therapeutische mittel
US4777260A (en) * 1985-12-18 1988-10-11 Eli Lilly And Company Synthesis of nizatidine intermediate
CA1277325C (en) * 1985-12-18 1990-12-04 Bruce A. Slomski Synthesis of nizatidine
ES2053462T3 (es) * 1987-04-06 1994-08-01 Heumann Pharma Gmbh & Co Procedimiento para la produccion de derivados de nitroetano.
ES2007959A6 (es) * 1988-07-11 1989-07-01 Vinas Lab Procedimiento para la obtencion de derivados tiazolicos.
ES2151480T3 (es) * 1991-05-21 2001-01-01 Lilly Co Eli Procedimiento para preparar productos intermedios de nizatidina y compuestos relacionados.
ES2038922B1 (es) * 1991-12-30 1994-04-16 Fermentaciones Y Sintesis Espa Procedimiento para la obtencion de nizatidina.
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
AU662454B2 (en) * 1992-05-12 1995-08-31 Zeria Pharmaceutical Co., Ltd. Novel quaternary ammonium salts and use thereof as medicine
US5541335A (en) * 1994-07-11 1996-07-30 Torcan Chemical Ltd. Process for preparing nizatidine
US5470865A (en) * 1994-08-30 1995-11-28 Eli Lilly And Company Pharmaceutical composition
US6069256A (en) * 1996-09-11 2000-05-30 Knoll Aktiengesellschaft Process for the preparation of nizatidine
IT1299198B1 (it) * 1998-03-05 2000-02-29 Nicox Sa Sali nitrati di farmaci antiulcera
EP1140066A4 (en) 1998-11-17 2005-11-09 Nitromed Inc NITRO- AND NITROSYL COMPOUNDS OF H2 RECEPTOR ANTAGONISTS, COMPOSITIONS AND THEIR USES OF USE
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
WO2005115341A2 (en) * 2004-05-27 2005-12-08 Advanced Bionutrition Corporation Microparticles for oral delivery
US20080045575A1 (en) * 2004-12-29 2008-02-21 Van Dyke Thomas E Delivery of H2 Antagonists
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
US20090275622A1 (en) * 2008-04-30 2009-11-05 Prasoona Linga Nizatidine formulations
ES2924478T3 (es) 2012-03-15 2022-10-07 Boehringer Ingelheim Vetmedica Gmbh Formulación de comprimidos farmacéuticos para el sector médico veterinario, método de producción y uso de los mismos
CN105377235A (zh) 2013-07-19 2016-03-02 勃林格殷格翰动物保健有限公司 含有防腐的醚化的环糊精衍生物的液体水性药物组合物
KR102308973B1 (ko) 2013-12-04 2021-10-08 베링거잉겔하임베트메디카게엠베하 개선된 피모벤단의 약제학적 조성물
EP2929884A1 (en) 2014-04-11 2015-10-14 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of dabigatran and h2-receptor antagonists
WO2015169957A1 (en) 2014-05-09 2015-11-12 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical combinations of rivaroxaban and h2-receptor antagonists
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
US3917593A (en) * 1972-05-22 1975-11-04 Smithkline Corp N-alkenyl and N-alkynyl (2-quinolyl)thio-acetamides
US3853865A (en) * 1972-06-26 1974-12-10 Smithkline Corp N-aminomethyl-2-amino(and 2-amino-methyl)-2-heterocyclic-thioacetamides
GB1421792A (en) * 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
US4191769A (en) * 1974-03-12 1980-03-04 Smith Kline & French Laboratories Limited Isothiourea compounds and pharmacological use
US4061637A (en) * 1974-05-14 1977-12-06 Istituto Luso Farmaco D'italia S.R.L. Certain 4-aryl-5-(4-phenylpiperazino)alkyl-4-thiazolin-2-ones
US4173644A (en) * 1975-02-03 1979-11-06 Smith Kline & French Laboratories Limited Thiourea compounds, compositions and methods and use
US4166856A (en) * 1975-05-21 1979-09-04 Smith Kline & French Laboratories Limited Thiazole and isothiazole derivative as blockers of histamine H2 -receptors
GB1574214A (en) * 1976-03-11 1980-09-03 Smith Kline French Lab Amidines
GB1602458A (en) * 1977-05-05 1981-11-11 Smith Kline French Lab Bisamidines as histamine h2-antagonists
JPS5444660A (en) * 1977-08-29 1979-04-09 Yamanouchi Pharmaceut Co Ltd Heterocyclic compound and its preparation
DE2835695A1 (de) * 1977-08-29 1979-03-15 Yamanouchi Pharma Co Ltd Neue heterocyclische verbindungen, verfahren zu ihrer herstellung und arzneimittel, die diese enthalten
US4210658A (en) * 1977-09-08 1980-07-01 Smith Kline & French Laboratories Limited Amidinosulphonic acid derivatives
DE2905134A1 (de) * 1978-02-17 1979-08-23 Degussa Neue acylierte aminoalkyl-cyanoguanidine mit einem heterocyclischen rest
EP0006679B1 (en) * 1978-05-24 1982-07-21 Imperial Chemical Industries Plc Antisecretory thiadiazole derivatives, processes for their manufacture and pharmaceutical compositions containing them
US4200578A (en) * 1978-12-18 1980-04-29 Bristol-Myers Company Thiazole derivatives

Also Published As

Publication number Publication date
EP0049618A1 (en) 1982-04-14
KR850001795B1 (ko) 1985-12-21
ES505950A0 (es) 1983-01-01
JPS5791980A (en) 1982-06-08
ES8306135A1 (es) 1983-05-01
RO82215B (ro) 1983-06-30
US4375547A (en) 1983-03-01
FI76570B (fi) 1988-07-29
FI76570C (fi) 1988-11-10
PL238035A1 (en) 1983-02-28
ES514868A0 (es) 1983-05-01
NL930107I1 (nl) 1993-10-18
PL130526B1 (en) 1984-08-31
PT73757A (en) 1981-11-01
NO155885B (no) 1987-03-09
ZA816817B (en) 1983-05-25
IE51603B1 (en) 1987-01-21
GB2084581A (en) 1982-04-15
JPH021141B2 (OSRAM) 1990-01-10
DK12391A (da) 1991-01-24
SU1184443A3 (ru) 1985-10-07
RO85815A (ro) 1984-11-25
EG15678A (en) 1986-12-30
HU188697B (en) 1986-05-28
NO813334L (no) 1982-04-05
IL63980A0 (en) 1982-01-31
AU7594581A (en) 1982-04-08
IE812285L (en) 1982-04-02
RO85815B (ro) 1984-11-30
ES8301950A1 (es) 1983-01-01
PH18135A (en) 1985-04-03
RO82215A (ro) 1983-07-07
GB2084581B (en) 1985-02-27
GR75023B (OSRAM) 1984-07-12
CS227015B2 (en) 1984-04-16
CY1351A (en) 1987-04-24
IL63980A (en) 1986-04-29
PL130626B1 (en) 1984-08-31
EP0049618B1 (en) 1985-08-14
DE3171819D1 (en) 1985-09-19
DK435181A (da) 1982-05-12
YU42728B (en) 1988-12-31
DD200371A5 (de) 1983-04-20
DK164056C (da) 1992-09-28
DK167759B1 (da) 1993-12-13
NL930107I2 (nl) 1997-02-03
HK15987A (en) 1987-02-27
DK164056B (da) 1992-05-04
LU88293I2 (fr) 1994-05-04
UA6081A1 (uk) 1994-12-29
PT73757B (en) 1983-01-13
PL233295A1 (OSRAM) 1982-12-20
BG60249B2 (en) 1994-03-24
YU236481A (en) 1983-10-31
AU542553B2 (en) 1985-02-28
CA1166248A (en) 1984-04-24
KR830007602A (ko) 1983-11-04
NZ198523A (en) 1985-12-13
DK12391D0 (da) 1991-01-24
BG60249B1 (bg) 1994-03-24
MY8700247A (en) 1987-12-31
NO155885C (no) 1987-06-17
MX5723A (es) 1993-12-01
FI813058L (fi) 1982-04-03

Similar Documents

Publication Publication Date Title
AR241439A1 (es) Preparacion de n-tiazolil-metiltio-alquil-n'-(ciano, carbamoil, nitro p-alquilfenilsulfonil o alquilsulfonil) guanidinas o n'-ciano carbamido tioatos.
ES8705855A1 (es) Procedimiento para preparar nuevos compuestos sulfonilaminoetilicos
ES8605500A1 (es) Procedimiento para preparar derivados de acidos fenilaceticos.
DK402280A (da) Fremgangsmaade til fremstilling af diphenulethere
ES494791A0 (es) Procedimiento para la preparacion de acidos oxirancarboxili-cos sustituidos
TR21759A (tr) Suebstituee edilmis fenilsuelfoniluere tuerevleri,bunlarin meydana getirilmesine mahsus usul ve herbisid olarak kullanimlari ve bunlarin meydana getirilmesine mahsus yeni ara ueruenler
ES8604562A1 (es) Un procedimiento para la preparacion de nuevos derivados de quinazolina e isoquinolina
JPS56103168A (en) Thiazole derivative, its preparation, and antihistaminic agent containing the same
JPS57165387A (en) Prparation of fluoran derivative
YU105587A (en) Process for obtaining derivatives of 1,3,5-cyclohexantriones
ES466887A2 (es) Un procedimiento de preparacion de una fenilamidina substituida.
ES8604578A1 (es) Procedimiento para preparar derivados de 1,4-dihidropiridina
ES8106168A1 (es) Procedimiento para la preparacion de derivados diazoicos.
ES8504129A1 (es) Procedimiento para preparar derivados de 2(1h) piridona.
BR8702905A (pt) Processo para preparacao de composto herbicida e composicao herbicida
ES2054231T3 (es) Procedimiento para preparar oxido de estireno.
AR248391A1 (es) Procedimiento para la manufactura de 2-alcoximetil-acroleina, compuestos intermediarios prepararados a partir de la misma y procedimiento para preparar dichos intermediarios.
TR200002950T2 (tr) Matris-Metaloproteinaz önleyicilerinin üretiminde faydalı alkilleştirici engellenmiş sülfonamitlerin işlemi.
KR910006257A (ko) 안트라닐산 유도체 및 이를 함유하는 구충제 조성물
ES531933A0 (es) Un procedimiento para preparar un derivado de imidazolinona
ES2032461T3 (es) Procedimiento para preparar derivados de indol.
HUT43598A (en) Process for production of derivatives of new 4-hidroxiquinoline carbonic acid and medical compound containing thereof
JPS5740479A (en) Preparation of benzofuran derivative and its acid addition salt
GB1449094A (en) Poly -dialkyl-phosphonoalkyl- carbamates and their use as flame- retarding agents on textile materials
ES480969A1 (es) Procedimiento para la aclaracion optica de materiales organicos, en especial de tipo textil.